Pathologic Constriction (Stenosis) Summary

Networked: 33910 relevant articles (1962 outcomes, 2592 trials/studies) for this Disease

Key Drugs and Agents for Pathologic Constriction

1. glucuronyl glucosamine glycan sulfate (Vessel) : 78 outcomes 162 studies in 2926 results : IBA
   
2. Phenobarbital (Luminal) : 52 outcomes 97 studies in 1609 results : FDA 1
   
3. Mitomycin (Mitomycin-C) : 23 outcomes 16 studies in 104 results : FDA 7 Generic
   
4. nitinol : 17 outcomes 17 studies in 141 results : IBA
   
5. 1-phenyl-3,3-dimethyltriazene (PDT) : 15 outcomes 11 studies in 53 results : IBA
   
6. Aspirin (Acetylsalicylic Acid) : 14 outcomes 41 studies in 164 results : FDA 80 Generic
   
7. Polytetrafluoroethylene (Teflon) : 14 outcomes 25 studies in 209 results : FDA 1
   
8. Paclitaxel (Taxol) : 14 outcomes 17 studies in 115 results : FDA 13 Generic
   
9. Plastics : 13 outcomes 11 studies in 319 results : IBA
   
10. Oxygen : 12 outcomes 6 studies in 116 results : IBA
    

Diseases Related to Pathologic Constriction

1. Pathologic Constriction (Stenosis)
2. Stroke (Strokes)
3. Neoplasms (Cancer)
4. Deglutition Disorders (Dysphagia)
5. Thrombosis (Thrombus)

Key Therapies for Pathologic Constriction

1. Stents : 525 outcomes 479 studies in 6162 results
   
2. Angioplasty (Angioplasty, Transluminal) : 190 outcomes 209 studies in 2834 results
   
3. Transplants (Transplant) : 168 outcomes 287 studies in 4159 results
   
4. Balloon Dilation : 109 outcomes 45 studies in 817 results
   
5. Catheters : 80 outcomes 67 studies in 1543 results